LAWRENCE, Mass., Aug. 26, 2011 /PRNewswire/ -- As potential hurricanes and severe weather approach, NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, is reminding patients that it is important to be prepared to ensure continuity of therapy in the event of a natural disaster or other potentially disruptive non-medical event. NxStage’s “Are You Ready”is a comprehensive emergency preparedness guidebook to help patients using NxStage Medical’s System One home hemodialysis system and their care partners. Centers and NxStage patients can access a free electronic version of the “Are You Ready?” guidebook for download at www.nxstage.com/areyouready.
(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )
Missing dialysis treatments can be a matter of life and death for patients with end-stage renal disease (ESRD). However, the portability of the System One allows home patients to take their machines and supplies with them in case of evacuation. And, if confined to their homes, NxStage patients can typically continue with their daily treatment regimen. “Are You Ready?” helps patients and their care partners prepare in advance for these types of situations.
The centerpiece of “Are You Ready” is a comprehensive workbook that includes instructions for the following:
- Developing and testing an evacuation plan
- Ordering emergency reserves of home dialysis equipment and supplies
- Consolidating emergency contact information and critical medical/identification documents
- Organizing visible access to prescription information, as well as information on allergies or specific dietary guidelines or restrictions.
- Alerting local utility companies in the event water or electricity supply is compromised
- Accessing emergency services and options for transportation
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at http://www.nxstage.com.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “plan,” and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including factors that are discussed in NxStage’s filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2011. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com
SOURCE NxStage Medical, Inc.
